Global human insulin market reaching US$49,197.3 million by 2020

Posted January 29, 2016 by MRRSE16

Asia Pacific is predicted to exhibit a swift growth rate in the worldwide human insulin market in the following five years. China and India are predicted to be the fastest developing human insulin markets within Asia Pacific.

Report Description

Albany, New York, 04 May 2015 : Increasing prevalence of diabetes and upsurge in the number of lifestyle-related conditions such as obesity are augmenting the growth of the global human insulin market. To explore this and many more trends further, Market Research Reports Search Engine (MRRSE) has added a new report titled ‘‘ Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020” to its repository. The report, published by Persistence Market Research, covers the present status and forthcoming trends and opportunities in the market for human insulin. The report also offers much information besides in the form of descriptive tables and analytical graphs.

As per the Centers for Diseases Control and Prevention (CDC), a U.S.-based national public health establishment, more than 33% kids and teenagers were obese in 2012 in the U.S. This bears out the importance of diabetes and the various conditions associated with it on the human insulin market. In the global perspective, strict administrative prerequisites for medication approval and uneven pricing and constrained access to human insulin in developing nations are controlling the development of the human insulin market.

Complete Report with TOC @


As per this report, the global human insulin market had a total value of US$24,332.6 million in 2014 and is predicted to develop at a CAGR of 12.4% between 2014 and 2020, reaching US$49,197.3 million by 2020. The human insulin market is segmented on the basis of the type of diseases, insulin, and geography. North America has the largest market and Asia-Pacific has the fastest growing market for human insulin. In terms of type of human insulin, modern human insulin represents the largest and fastest growing segment of this market.

Key Players

Some of the major players in the human insulin market are Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, Tonghua Dongbao Pharmaceutical Co., Ltd., Adocia, Merck & Co., Inc., Pfizer, Inc., Wockhardt and others.

Request a Free Sample Copy of the Report @


MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.

Corporate Office
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MRRSE
Country United States
Categories Business
Tags Human Insulin Market , Human Insulin Market Growth , Human Insulin
Last Updated January 29, 2016